Lilly Buys Psychedelics Maker Atai Beckley for $2.8B
Eli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
Using wallets to keep your crypto safe is essential for security. Discover the best wallet options to secure your investments.
23,072 articlesEli Lilly unveils a landmark $2.8 billion cash deal to acquire Atai Beckley, aiming to push a DMT-like therapy for tr...
A new oral Wegovy launch is reshaping GLP-1 dynamics. Even with Novo Nordisk gaining ground, Eli Lilly stock could st...
Micron Technology reports a robust third quarter, beating expectations and raising guidance amid a fraught memory mar...
D.R. Horton posted stronger third-quarter profitability but trimmed its full-year guidance, signaling a pivot to marg...
Capital Group's Dividend Value ETF has significantly outperformed SCHD since February 2022, prompting renewed debate ...
Carvana faces a pivotal earnings night as investors weigh margins and liquidity against revenue growth in a choppy us...
Goodyear reports a strong Q4 with $105 million in profit, while an investor increases exposure to $15 million. This p...
CoreWeave sits at the intersection of explosive AI demand and a looming debt challenge. A multi-billion backlog canno...
Two lesser-known robotics stocks beat earnings, underscoring a broader wave of AI-powered automation beyond the famil...
A 61-year-old CEO at a major U.S. insurer shapes a six-day workout schedule, guided by his 23-year-old son, while ste...
Three leading tech ETFs battle for AI-era glory. This story breaks down Nvidia exposure, valuation, and risk to answe...
CrowdStrike accelerates an acquisition push as Palo Alto Networks doubles down on platform strategy. Both leaders rep...